GeneSort's Corporate Minority Round

GeneSort raised a round of funding on July 16, 2018. Investors include ACT.

GeneSort is a molecular diagnosis company that specializes in personalized medicine in cancer and hereditary diseases. GeneSort specializes in genetic analysis of deep tissue and enables recognizing s…

Articles about GeneSort's Corporate Minority Round: